# Prenuvo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prenuvo

- Industry: Healthcare
- Headquarters: Redwood City, US
- Website: www.prenuvo.com
- Total disclosed funding: $126M
- Latest round: Series B (Jun 20, 2024)
- Investors on record: 3

## About

Based in California, US, Prenuvo Inc. operates as a healthcare chain offering MRI screening of the whole body for cancer detection. In October 2022, the firm raised USD 70 million in Series A equity and debt funding led by Felicis Ventures along with the participation of other individual investors. The company, as of October 2022, operates in 6 locations including Chicago, Boston, and New York city in US and Toronto, Canada, and is led by its founder and CEO, Andrew Lacy.

The company offers radiation-free whole-body imaging for early detection of cancer and other diseases, through its MRI machine which only takes 20 mins to 60 minutes to complete instead of traditional methods that take 3 to 4 hours. The company’s scan through its software and AI technology covers 26 regions or organs of the body and can diagnose over 500 health conditions including most solid tumors at Stage 1.

Prenuvo has grown in revenue by 240% year-over-year as of October 2022 and it generates its revenue by offering its scan services under different prices including USD 999 for a torso scan, USD 1799 for a head and torso scan, and USD 2499 for a full body scan.

The firm plans to utilize its October 2022 funding to build its artificial intelligence team, as well as for the investment in new radiology tools and for its national expansion.

## Funding rounds

- Series B, Jun 20, 2024, $85M — Forerunner Ventures, Felicis Ventures, Left Lane Capital
- Series A, Jun 21, 2021, $41M — Felicis Ventures

## Investors

- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Series A, Series B
- Forerunner Ventures (https://capitalatlas.ai/funds/forerunner-ventures) — Series B
- Left Lane Capital (https://capitalatlas.ai/funds/left-lane-capital) — Series B